Shockwave Therapy (ESWT) Research

This randomized controlled trial examined whether adding extracorporeal shockwave therapy (ESWT) to conventional physical therapy improves outcomes in patients with severe knee osteoarthritis.

Results showed significant functional improvements in the ESWT group compared to physical therapy alone, demonstrating that ESWT can benefit even advanced osteoarthritis cases.

This randomized controlled trial compared extracorporeal shockwave therapy (ESWT), ultrasound therapy, and deep friction massage for treating lateral epicondylitis (tennis elbow).

ESWT demonstrated superior outcomes for both pain reduction and functional improvement compared to ultrasound, with benefits persisting through 6-month follow-up.

This systematic review and meta-analysis examined the efficacy and safety of extracorporeal shockwave therapy for various upper limb tendon conditions.

Analysis of multiple randomized controlled trials found consistent evidence supporting ESWT effectiveness for rotator cuff tendinopathy, lateral epicondylitis, and biceps tendonitis, with a favorable safety profile.

This systematic review and meta-analysis evaluated the effectiveness of extracorporeal shockwave therapy (ESWT) for treating tendinopathies across both upper and lower extremities. The review synthesized evidence from randomized controlled trials comparing ESWT to placebo or sham treatments for conditions including lateral epicondylitis, rotator cuff tendinopathy, patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis.

The pooled results demonstrated that ESWT produced statistically significant improvements in both pain reduction and functional outcomes across multiple tendinopathy types. The analysis examined both calcific and non-calcific tendinopathies, finding benefits in both categories. The findings support ESWT as an effective non-invasive treatment option for chronic tendon disorders that have not responded to conventional conservative management.

The review strengthens the evidence base for ESWT as a versatile intervention applicable across different anatomical sites and tendinopathy types, suggesting it should be considered as part of the treatment algorithm for persistent tendon pain in both upper and lower limbs.

This systematic review and meta-analysis examined the effectiveness of extracorporeal shockwave therapy (ESWT) specifically for rotator cuff tendinopathy, one of the most common causes of shoulder pain. Published in BMC Musculoskeletal Disorders, the review pooled data from randomized controlled trials evaluating ESWT against control treatments for rotator cuff conditions.

The analysis assessed multiple validated outcome measures including Visual Analog Scale (VAS) for pain, Constant-Murley Score (CMS), UCLA Shoulder Score, range of motion (ROM), American Shoulder and Elbow Surgeons (ASES) score, and total effective rate (TER). Across these measures, ESWT consistently demonstrated significant improvements in pain relief, shoulder function, and mobility compared to control groups.

The comprehensive evaluation across six different outcome domains provides robust evidence supporting ESWT as an effective treatment for rotator cuff tendinopathy. The findings suggest ESWT can meaningfully improve both the pain experience and functional capacity in patients with this common shoulder condition, offering a non-invasive alternative to corticosteroid injections or surgery.

This systematic review and meta-analysis evaluated the efficacy of extracorporeal shockwave therapy (ESWT) for myofascial pain syndrome (MPS) specifically affecting the trapezius muscle. Published in Archives of Physical Medicine and Rehabilitation, the study addressed a common pain condition characterized by trigger points, referred pain patterns, and restricted range of motion in the neck and shoulder region.

The review synthesized data from randomized controlled trials comparing ESWT to sham treatment or conventional therapies for trapezius MPS. Primary outcomes included pain intensity measured via VAS or numeric rating scales and functional outcomes including range of motion and disability measures. The pooled analysis demonstrated that ESWT produced significant improvements in both pain and function compared to control groups.

The findings are clinically relevant because trapezius myofascial pain is extremely prevalent, particularly among office workers and those with repetitive strain. ESWT's ability to target trigger points and reduce pain offers a valuable treatment option beyond manual trigger point therapy, dry needling, or medication. The results support incorporating ESWT into the management of chronic trapezius MPS, especially for patients who have not responded to first-line conservative treatments.